Healthy high growth potential

Results

1535

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1535 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
LPK
€13.05-13.3%63.9%€326.5m€22.753.2116.6%0%Tech
WAYS
SEK 37.80-4.1%-2.3%SEK 339.4mSEK 58.00201.178.5%0%Tech
CDR
zł258.70-1.7%0.3%zł25.5bzł236.0550.139.6%0.4%Media
AGP
€7.11-2.1%-12.7%€130.0m€8.5726.139.1%n/aCapital Goods
GOLDR
NOK 7.863.3%n/aNOK 450.6mn/a20.786.0%n/aMaterials
AAZ
UK£4.05-0.6%153.1%UK£457.4mUK£5.6835.725.9%0.7%Materials
FWRY
ج.م19.211.1%41.4%ج.م65.4bج.م22.4524.626.4%n/aDiversified Financials
MDGL
US$516.741.8%24.6%US$12.0bUS$678.069.363.7%n/aPharmaceuticals & Biotech
TMGH
ج.م97.70-0.1%77.6%ج.م201.3bج.م141.9013.035.9%0.3%Real Estate Management and Development
SAUD3
R$13.921.1%7.1%R$40.7bR$17.6938.631.9%5.8%Healthcare
RHM
€1,155.40-3.9%-28.8%€54.2b€1,679.3844.630.5%1.0%Capital Goods
LITE
US$866.71-6.4%626.3%US$78.9bUS$1,148.3025.8104.4%n/aTech
CRDO
US$230.57-11.3%102.2%US$43.1bUS$283.2391.027.7%n/aSemiconductors
SPCX
US$136.97-2.2%n/aUS$1.8tUS$216.3380.756.5%n/aTelecom
TGTX
US$54.2711.3%84.3%US$7.2bUS$69.7117.421.3%n/aPharmaceuticals & Biotech
MOD
US$197.68-5.6%40.8%US$10.1bUS$310.2972.851.3%n/aCapital Goods
AXSM
US$207.77-2.8%75.3%US$10.9bUS$285.4214.061.1%n/aPharmaceuticals & Biotech
NVDA
US$214.72-4.6%20.6%US$5.2tUS$304.7332.622.9%0.5%Semiconductors
688183
CN¥107.58-7.3%65.3%CN¥90.1bCN¥159.0043.934.2%0.8%Tech
002970
CN¥50.46-3.6%0.9%CN¥9.2bn/a28.236.5%2.0%Automobiles
2171
HK$13.53-9.9%-35.8%HK$8.0bHK$18.3350.5131.5%n/aPharmaceuticals & Biotech
501423
₹3,321.90-1.4%57.6%₹152.8b₹3,916.6786.437.3%0.09%Capital Goods
1729
HK$15.25-7.8%27.3%HK$34.0bHK$28.7543.437.1%0.3%Capital Goods
301345
CN¥250.17-1.7%28.4%CN¥27.3bCN¥320.3530.131.5%1.2%Automobiles
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St